TG Therapeutics, Inc. Share Price
NASDAQ: TGTXHealthcare
Live TG Therapeutics, Inc. Share Price Chart
O H L
TG Therapeutics, Inc. Performance Overview
Days Range
▼
$53.35Low
$54.70High
Markets Today
| Previous Close | $54.29 |
|---|---|
| Open | $54.06 |
| Volume | 1,544,872 |
| Day's Range | $53.35 - $54.70 |
| 52W Range | $26.76 - $59.30 |
| Market Cap | $8.31 B |
Historical Performance
| 1M Returns | -3.71 |
|---|---|
| 3M Returns | -2.81 |
| 6M Returns | +60.02 |
| 1Y Returns | +46.65 |
| 5Y Returns | +73.12 |
| 10Y Returns | +540.26 |
TG Therapeutics, Inc. Fundamentals
| Market Cap | $8.31 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 19.77 |
| PEG Ratio | N/A |
| Revenue | $616.29 M |
| ROE TTM | 1.03 |
| EPS TTM | $2.75 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 13.76 |
| EBITDA | $123.38 M |
| Profit Margin | 72.56 |
| Market Cap | $8.31 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 19.77 |
| PEG Ratio | N/A |
| Revenue | $616.29 M |
| ROE TTM | 1.03 |
| EPS TTM | $2.75 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 13.76 |
| EBITDA | $123.38 M |
| Profit Margin | 72.56 |
TG Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $120.86 M | $141.15 M | $161.71 M | $192.57 M | $204.92 M | $240.34 M |
| Gross Profit + | $105.31 M | $122.21 M | $133.62 M | $154.43 M | $171.41 M | $199.14 M |
| Operating Income | $8.62 M | $34.84 M | $29.36 M | $50.49 M | $34.80 M | $21.67 M |
| EBITDA | $8.63 M | $34.86 M | $29.52 M | $50.38 M | $34.83 M | $21.73 M |
| Interest Expense | -$6.76 M | -$6.72 M | -$6.72 M | -$6.53 M | -$7.67 M | -$16.57 M |
| Depreciation | $8.00 K | $13.00 K | $156.00 K | -$118.00 K | $32.00 K | $53.00 K |
| Income Before Tax | $5.47 M | $30.92 M | $25.91 M | $45.09 M | $20.36 M | $10.23 M |
| Income Tax Expense | $408.00 K | $2.73 M | -$364.99 M | $22.06 M | $586.00 K | $2.45 M |
| Net Income + | $5.06 M | $28.19 M | $390.89 M | $23.04 M | $19.78 M | $7.78 M |
| Net Profit Margin | 4.19% | 19.97% | 241.73% | 11.96% | 9.65% | 3.24% |
TG Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $159.00 K | $159.00 K | $159.00 K | $159.00 K | $160.00 K | $160.00 K |
| Reserve & Surplus | -$1.52 B | -$1.50 B | -$1.11 B | -$1.08 B | -$1.06 B | -$1.05 B |
| Non-Current Liabilities | $259.19 M | $254.29 M | $261.00 M | $261.47 M | $758.60 M | $767.05 M |
| Current Liabilities | $160.21 M | $171.89 M | $156.81 M | $153.76 M | $187.11 M | $268.49 M |
| Total Liabilities | $419.40 M | $426.18 M | $417.81 M | $415.23 M | $945.71 M | $1.04 B |
| Fixed Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Assets | $644.51 M | $663.96 M | $599.76 M | $630.76 M | $1.09 B | $1.15 B |
| Total Assets | $656.69 M | $702.61 M | $1.03 B | $1.06 B | $1.53 B | $1.64 B |
TG Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $5.06 M | $28.19 M | $390.89 M | $23.04 M | $19.78 M | $7.78 M |
| Operating Cash Flow | -$28.71 M | $7.44 M | -$23.15 M | $19.66 M | -$17.89 M | $39.26 M |
| Investing Cash Flow | -$12.93 M | -$3.99 M | $46.36 M | -$15.64 M | -$9.86 M | $1.03 M |
| Financing Cash Flow | -$6.10 M | -$6.44 M | -$78.24 M | $1.06 M | $390.83 M | $85.00 K |
| Change in Cash | -$47.75 M | -$3.00 M | -$55.03 M | $5.08 M | $363.07 M | $40.38 M |
TG Therapeutics, Inc. Return Calculator
The TG Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$17,148
Invested Amount$10,000
Est. Returns$7,148
About TG Therapeutics, Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Popular Stocks
FAQs
What is the share price of TG Therapeutics, Inc. today?
TG Therapeutics, Inc. (TGTX) share price as of October 6, 2026 is $53.40. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of TG Therapeutics, Inc.?
Yes, Indian Investors can invest in the TG Therapeutics, Inc. (TGTX) Share by opening an international trading account with Angel One.
How can I purchase TG Therapeutics, Inc. shares in India?
Purchasing TG Therapeutics, Inc. (TGTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying TG Therapeutics, Inc. (TGTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of TG Therapeutics, Inc.?
Yes, you can purchase fractional shares of TG Therapeutics, Inc. (TGTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of TG Therapeutics, Inc.?
The market capitalization of TG Therapeutics, Inc. on October 6, 2026, is $8.31 B.
In which sector TG Therapeutics, Inc. belongs?
TG Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in TG Therapeutics, Inc. stocks?
In order to invest in TG Therapeutics, Inc. (TGTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
